While this work was in progress, Jia et al. reported that IPA potentiated immunotherapy in multiple cancer models by inducing H3K27 acetylation at the super-enhancer region of Tcf7, reprogramming CD8 T cell stemness8. The gene discussed is CD8A; the disease is cancer.